EE05406B1 - Memnopeptiidhend, selle valmistamine ja kasutamine ning seda sisaldav farmatseutiline kompositsioon - Google Patents

Memnopeptiidhend, selle valmistamine ja kasutamine ning seda sisaldav farmatseutiline kompositsioon

Info

Publication number
EE05406B1
EE05406B1 EEP200200480A EEP200200480A EE05406B1 EE 05406 B1 EE05406 B1 EE 05406B1 EE P200200480 A EEP200200480 A EE P200200480A EE P200200480 A EEP200200480 A EE P200200480A EE 05406 B1 EE05406 B1 EE 05406B1
Authority
EE
Estonia
Prior art keywords
memnopeptide
compound
preparation
pharmaceutical composition
composition containing
Prior art date
Application number
EEP200200480A
Other languages
English (en)
Inventor
Vertesy Laszlo
Kogler Herbert
Markus Astrid
Schiell Matthias
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200200480A publication Critical patent/EE200200480A/et
Publication of EE05406B1 publication Critical patent/EE05406B1/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EEP200200480A 2000-02-29 2001-02-15 Memnopeptiidhend, selle valmistamine ja kasutamine ning seda sisaldav farmatseutiline kompositsioon EE05406B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00104114A EP1130027A1 (de) 2000-02-29 2000-02-29 Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
PCT/EP2001/001661 WO2001064715A2 (en) 2000-02-29 2001-02-15 Memno peptides, a process for their preparation and their use

Publications (2)

Publication Number Publication Date
EE200200480A EE200200480A (et) 2004-02-16
EE05406B1 true EE05406B1 (et) 2011-04-15

Family

ID=8167973

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200480A EE05406B1 (et) 2000-02-29 2001-02-15 Memnopeptiidhend, selle valmistamine ja kasutamine ning seda sisaldav farmatseutiline kompositsioon

Country Status (30)

Country Link
US (1) US6627604B2 (et)
EP (2) EP1130027A1 (et)
JP (1) JP4787449B2 (et)
KR (1) KR100997073B1 (et)
CN (1) CN1274715C (et)
AR (1) AR029808A1 (et)
AT (1) ATE313556T1 (et)
AU (2) AU2001250318B2 (et)
BR (1) BR0108757A (et)
CA (1) CA2401032C (et)
CY (1) CY1105550T1 (et)
CZ (1) CZ303552B6 (et)
DE (1) DE60116063T2 (et)
DK (1) DK1261625T3 (et)
EE (1) EE05406B1 (et)
ES (1) ES2254394T3 (et)
HK (1) HK1052712B (et)
HR (1) HRP20020703B1 (et)
HU (1) HU228067B1 (et)
IL (2) IL151458A0 (et)
ME (1) ME00379B (et)
MX (1) MXPA02007845A (et)
NO (1) NO329082B1 (et)
NZ (1) NZ521036A (et)
PL (1) PL206818B1 (et)
RU (1) RU2261254C2 (et)
SI (1) SI1261625T1 (et)
SK (1) SK287310B6 (et)
WO (1) WO2001064715A2 (et)
ZA (1) ZA200206841B (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308613B1 (it) 1999-02-17 2002-01-09 Pharmacia & Upjohn Spa Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
DE10050091A1 (de) * 2000-10-09 2002-04-25 Biotechnolog Forschung Gmbh Casein-Peptidfragmente mit wachstumsbeeinflußender Aktivität auf Zellkulturen
ITMI20010129A1 (it) * 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
US7160917B2 (en) * 2002-12-13 2007-01-09 Sanofi-Aventis Deutschland Gmbh Spirobenzofuran lactams and their derivatives, processes for their preparation and use thereof
DE10258650A1 (de) * 2002-12-13 2004-06-24 Aventis Pharma Deutschland Gmbh Neue Spirobenzofuranlactame und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
DE102012016127A1 (de) 2011-08-31 2013-02-28 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995004530A1 (en) * 1993-08-06 1995-02-16 Smithkline Beecham Corporation Endothelin receptor antagonists
JPH07330622A (ja) * 1994-06-06 1995-12-19 Asahi Chem Ind Co Ltd 新規生理活性物質スタキボシンd及びその製法
JPH08283118A (ja) * 1995-04-07 1996-10-29 Kao Corp 美白剤
JPH10251262A (ja) * 1997-01-13 1998-09-22 Mercian Corp プロテアーゼ阻害物質およびその製造方法
DE19731571A1 (de) * 1997-07-23 1999-01-28 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19754082A1 (de) * 1997-12-05 1999-06-10 Knoll Ag Methode zur Bekämpfung der Fettleibigkeit
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben

Also Published As

Publication number Publication date
CZ303552B6 (cs) 2012-12-05
DE60116063T2 (de) 2006-08-03
NZ521036A (en) 2004-02-27
EP1130027A1 (de) 2001-09-05
US20010031857A1 (en) 2001-10-18
ZA200206841B (en) 2003-07-03
IL151458A0 (en) 2003-04-10
HUP0204584A2 (hu) 2003-04-28
AU2001250318B2 (en) 2005-09-08
BR0108757A (pt) 2002-12-10
SI1261625T1 (sl) 2006-04-30
CZ20022904A3 (cs) 2002-11-13
HUP0204584A3 (en) 2005-09-28
HK1052712B (zh) 2007-01-12
NO329082B1 (no) 2010-08-16
AR029808A1 (es) 2003-07-16
RU2261254C2 (ru) 2005-09-27
DK1261625T3 (da) 2006-04-18
NO20024105L (no) 2002-10-28
US6627604B2 (en) 2003-09-30
RU2002125877A (ru) 2004-01-10
SK287310B6 (sk) 2010-06-07
EP1261625B1 (en) 2005-12-21
IL151458A (en) 2008-08-07
CN1406243A (zh) 2003-03-26
KR20020077508A (ko) 2002-10-11
KR100997073B1 (ko) 2010-11-30
HU228067B1 (en) 2012-09-28
HRP20020703B1 (en) 2011-01-31
NO20024105D0 (no) 2002-08-28
ES2254394T3 (es) 2006-06-16
DE60116063D1 (de) 2006-01-26
SK12262002A3 (sk) 2003-02-04
MEP59108A (en) 2011-05-10
EP1261625A2 (en) 2002-12-04
CA2401032C (en) 2012-04-10
WO2001064715A2 (en) 2001-09-07
WO2001064715A3 (en) 2002-03-21
PL358300A1 (en) 2004-08-09
AU5031801A (en) 2001-09-12
CA2401032A1 (en) 2001-09-07
HK1052712A1 (en) 2003-09-26
HRP20020703A2 (en) 2004-12-31
ATE313556T1 (de) 2006-01-15
EE200200480A (et) 2004-02-16
PL206818B1 (pl) 2010-09-30
CY1105550T1 (el) 2010-07-28
JP2004512257A (ja) 2004-04-22
MXPA02007845A (es) 2002-11-29
ME00379B (me) 2011-05-10
CN1274715C (zh) 2006-09-13
JP4787449B2 (ja) 2011-10-05

Similar Documents

Publication Publication Date Title
EE05220B1 (et) Bis-arüülühend, seda sisaldav ravimpreparaat ning ühendi kasutamine kaaliumikanali blokaatorina toimiva ravimi valmistamiseks
EE05475B1 (et) Superantigeeni sisaldav konjugaat, konjugaadi kasutamine ja konjugaati sisaldav farmatseutiline kompositsioon
EE05183B1 (et) Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
EE200300240A (et) Arüülitud furaan- ja tiofeenkarboksamiid, seda sisaldav ravimpreparaat ning ühendi kasutamine kaaliumikanali blokaatorina toimiva ravimi valmistamiseks
EE200200487A (et) Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
NO20025450L (no) Ny farmasöytisk sammensetning
EE200300236A (et) 1,2-difenüülasetidinoonid, nende kasutamine, ravim ja selle valmistamismeetod
EE200300080A (et) Polüarüülkarboksamiidühendid, nende valmistamine ja kasutamine lipiiditaset alandavate toimeainetena ning neid sisaldav farmatseutiline kompositsioon
DK1524266T3 (da) Farmaceutisk sammensætning
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
HUP0400636A3 (en) Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
EE200300587A (et) Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine
FI991485A0 (fi) Uusi farmaseuttinen koostumus
EE200200486A (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
EE200200617A (et) (Tio)karbamiidi derivaat, seda sisaldav farmatseutiline preparaat, selle valmistamine ning kasutamine VIIa-teguri inhibiitorina
EE200200399A (et) Pürroolirea ühend, selle valmistamine ja kasutamine lipiidi- ja kolesteroolitaset alandava ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
EE200100096A (et) Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine ravimina
EE200200342A (et) Asendatud 8-arüülkinoliinid, nende kasutamine, farmatseutiline kompositsioon ja prekursorühend
EE200300488A (et) Lipiiditaset alandava toimega bifenüülkarboksamiidühend, meetod selle valmistamiseks ning seda sisaldav ravimkompositsioon
NO20032614D0 (no) Farmasöytisk sammensetning med forbedret absorbabilitet
EE200200544A (et) Kabergoliini kristallvorm II, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
EE200300398A (et) Isoksasoliini derivaat, selle saamine ja kasutamine depresioonivastase ravimi valmistamiseks ning seda sisaldav ravimkompositsioon
ATE366128T1 (de) Pharmazeutische zusammensetzung
EE200200109A (et) Asendatud 3-fenüül-5-alkoksü-1,3,4-oksdiasool-2-oon, selle valmistamine ja kasutamine lipaasi inhibiitorina ning seda sisaldav ravim
EE05406B1 (et) Memnopeptiidhend, selle valmistamine ja kasutamine ning seda sisaldav farmatseutiline kompositsioon

Legal Events

Date Code Title Description
MM4A Lapsed by not paying the annual fees

Effective date: 20180215